STOCK TITAN

Adma Biologics Stock Price, News & Analysis

ADMA Nasdaq

Welcome to our dedicated page for Adma Biologics news (Ticker: ADMA), a resource for investors and traders seeking the latest updates and insights on Adma Biologics stock.

ADMA Biologics Inc. (ADMA) is a commercial-stage biopharmaceutical company advancing plasma-derived therapies for immune deficiencies and infectious diseases. This dedicated news hub provides verified updates on corporate developments, regulatory milestones, and clinical progress.

Investors and healthcare professionals will discover timely coverage of earnings announcements, FDA decisions, manufacturing innovations, and strategic partnerships. Our curated selection emphasizes ADMA’s operational achievements in plasma collection, biomanufacturing excellence, and therapeutic pipeline advancements.

Key updates include product authorization progress, financial disclosures, patent developments, and peer-reviewed research findings. All content undergoes rigorous verification to ensure accuracy for investment and industry analysis.

Bookmark this page for direct access to ADMA’s official communications and expertly contextualized news. Maintain awareness of critical developments impacting this innovative biologics manufacturer through Stock Titan’s trusted reporting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.4%
Tags
conferences
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.37%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.37%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.54%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.58%
Tags
AI
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.32%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.93%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.08%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.26%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.8%
Tags

FAQ

What is the current stock price of Adma Biologics (ADMA)?

The current stock price of Adma Biologics (ADMA) is $21.2 as of May 8, 2025.

What is the market cap of Adma Biologics (ADMA)?

The market cap of Adma Biologics (ADMA) is approximately 5.7B.
Adma Biologics

Nasdaq:ADMA

ADMA Rankings

ADMA Stock Data

5.68B
229.54M
2.64%
88.42%
6.01%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
RAMSEY